UM Miller School of Medicine: Cancer Research in the Wake of a Key FDA Decision on Minimal Residual Disease
April 11, 2025
April 11, 2025
MIAMI, Florida, April 11 -- The University of Miami Miller School of Medicine issued the following news:
* * *
Cancer Research in the Wake of a Key FDA Decision on Minimal Residual Disease
By Charlotte Schubert
It's been almost one year since the speed of multiple myeloma research got a big boost at the U.S. Food and Drug Administration (FDA).
Last April, a key agency committee ruled in favor of using a measurement called mini . . .
* * *
Cancer Research in the Wake of a Key FDA Decision on Minimal Residual Disease
By Charlotte Schubert
It's been almost one year since the speed of multiple myeloma research got a big boost at the U.S. Food and Drug Administration (FDA).
Last April, a key agency committee ruled in favor of using a measurement called mini . . .